65,437 trials
Influenza, Human
Primary: Number of Subjects (Unprimed) 6 to <36 Months Age With Local and Systemic Reactions After Any Vaccination for All Seasons, Comparison of Adjuvanted Trivalent Influenza…
Fibromyalgia
Primary: Change in Ventricular Lactate Levels in the Brain — -0.87; 0.32 international units (iu) — p=<0.05
Schizophrenia · Chronic Illness · Weight Gain
Primary: The Effect of Care Model Implementation on Treatment Appropriateness: Weight Service Utilization — 73; 38 participants — p=<0.01
Allergic Asthma
Primary: Percentage of Participants Not Experiencing a Protocol-defined Severe Exacerbation During the Study — 67.0; 47.7 Percentage of participants
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 — 7.70; 7.26; -0.27; -0.80 percent of HbA1c in blood — p=< 0.0001
Mild Traumatic Brain Injury · Concussion
Primary: The Feasibility of Inpatient Bedside Neurocognitive Testing of Pediatric Patients With Minor Traumatic Brain Injury. — 120 participants
Heart Failure
Primary: Rate of Adherence to Guideline Prescription — 4; 6 patients
Primary Biliary Cirrhosis
Primary: Part 1: Number of Participants With Alkaline Phosphatase (ALP) Response at Week 12 — 0 participants
Attention Deficit Hyperactivity Disorder
Primary: Long-term Maintenance of Efficacy of KAPVAY in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) as Measured by the Percentage of Treatment…
Depression
Primary: Hamilton Depression Rating Scale Remission Rates — 46.1; 17.6 Percentage of Remitters HDRS17
Tuberculosis · HIV Infections
Primary: CD4+ Lymphocyte Count — -136.0; -107.0 cells/mm^3
Multiple Sclerosis
Primary: Percentages of Patients With Treatment-emergent Adverse Events (TEAEs) or Treatment-emergent Serious Adverse Events (TESAEs) — 100; 100; 88.9; 100 percentage of…
HIV · HIV Lipodystrophy
Primary: Liver Fat — -2.0; 0.9 Change in hepatic lipid-to-water %
Head and Neck Cancer · Oral Complications of Radiation Therapy · Radiation Toxicity
Primary: Protocol Compliance of Intensity-modulated Radiotherapy Treatment Delivered — 9 participants
Heart Failure · Cardiomyopathy · Ventricular Dysfunction
Primary: Intervention Related Adverse Events — 0; 0 events